Alterity Therapeutics Analyst Ratings
Ladenburg Thalmann Maintains Buy on Alterity Therapeutics, Lowers Price Target to $10
Ladenburg Thalmann Initiates Alterity Therapeutics at Buy With $2 Price Target
Alterity Therapeutics Initiated at Buy by Ladenburg Thalmann
Alterity Therapeutics Price Target Announced at $2.00/Share by Ladenburg Thalmann
Alterity Therapeutics analyst ratings
Ladenburg Thalmann Initiates Coverage On Alterity Therapeutics with Buy Rating, Announces Price Target of $2
Goldman Sachs Adjusts Alterity Therapeutics' Price Target to $3 from $11, Keeps Neutral Rating
Alterity Therapeutics Price Target Cut to $3.00/Share From $11.00 by Goldman Sachs
Alterity Therapeutics Is Maintained at Neutral by Goldman Sachs
Alterity Therapeutics analyst ratings
Goldman Sachs Maintains Neutral on Alterity Therapeutics, Lowers Price Target to $3
No Data